Clinical Developments

TREKKA continually assesses and identifies market opportunities to identify the most compatible APIs with our CAPRO technology. As opportunities present themselves, TREKKA often seeks out options to advance its own development portfolio of proprietary and/or partnered pharmaceutical products.

Consequently, our CAPRO Polymer Drug Delivery Platform has allowed us to explore a new innovative formulation to address an unmet disease market by developing a new API that is in pre-market development.